Patents by Inventor Alex Adai

Alex Adai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10655184
    Abstract: Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: May 19, 2020
    Assignee: INTERPACE DIAGNOSTICS, LLC
    Inventors: Alex Adai, Anna Szafranska-Schwarzbach, Bernard Andruss, Stephan Albrecht Hahn
  • Publication number: 20180327856
    Abstract: Embodiments concern methods and compositions for characterizing or evaluating neoplastic pancreatic cells using miRNAs that are measured and used in calculations to determine a risk score for a patient.
    Type: Application
    Filed: November 30, 2017
    Publication date: November 15, 2018
    Inventors: Dennis Wylie, Anna E. Szafranska-Schwarzbach, Bernard Andruss, Alex Adai, Linda S. Lee, Darwin L. Conwell
  • Publication number: 20180066316
    Abstract: Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.
    Type: Application
    Filed: April 19, 2017
    Publication date: March 8, 2018
    Inventors: Alex Adai, Anna Szafranska-Schwarzbach, Bernard Andruss, Stephan Albrecht Hahn
  • Patent number: 9644241
    Abstract: Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: May 9, 2017
    Assignee: Interpace Diagnostics, LLC
    Inventors: Alex Adai, Anna Szafransak-Schwarzbach, Bernard Andruss, Stephan Albrecht Hahn
  • Publication number: 20140235469
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing prostate disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as prostate cancer.
    Type: Application
    Filed: October 28, 2013
    Publication date: August 21, 2014
    Applicant: ASURAGEN, INC.
    Inventors: Jeffrey SHELTON, Kevin KELNAR, Stephanie VOLZ, Alex ADAI, David BROWN
  • Patent number: 8597892
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing prostate disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as prostate cancer.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: December 3, 2013
    Assignee: Asuragen, Inc.
    Inventors: Jeffrey Shelton, Kevin Kelnar, Stephanie Volz, Alex Adai, David Brown
  • Publication number: 20130157272
    Abstract: Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.
    Type: Application
    Filed: September 13, 2012
    Publication date: June 20, 2013
    Inventors: Alex Adai, Anna Szafranska-Schwarzbach, Bernard Andruss, Stephan Albrecht Hahn
  • Publication number: 20100297652
    Abstract: This application describes miRNAs that may be used as serum or plasma biomarkers for characterizing prostate disease in a patient. These miRNA biomarkers may be used alone or in combination with other markers for the diagnosis, prognosis, or monitoring of diseases such as prostate cancer.
    Type: Application
    Filed: May 21, 2010
    Publication date: November 25, 2010
    Applicant: Asuragen, Inc.
    Inventors: Jeffrey Shelton, Kevin Kelnar, Stephanie Volz, Alex Adai, David Brown